{"id":61552,"date":"2024-11-11T12:05:20","date_gmt":"2024-11-11T12:05:20","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/11\/11\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/"},"modified":"2024-11-11T12:05:20","modified_gmt":"2024-11-11T12:05:20","slug":"avalo-therapeutics-to-present-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/","title":{"rendered":"Avalo Therapeutics to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"justify\">WAYNE, Pa. and ROCKVILLE, Md., Nov.  11, 2024  (GLOBE NEWSWIRE) &#8212; Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present at two upcoming investor conferences:<\/p>\n<p align=\"justify\"><strong>Stifel 2024 Healthcare Conference, New York<\/strong><br \/>Monday, November 18, 2024 at 3:35 PM ET<\/p>\n<p align=\"justify\"><strong>Piper Sandler 36th Annual Healthcare Conference, New York<\/strong><br \/>Wednesday, December 5, 2024 at 11:00 AM ET<\/p>\n<p align=\"justify\">Live webcasts and replays, when available, can be found under &#8220;News \/ Events&#8221; in the Investors section of the\u00a0Avalo Therapeutics website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d6xlaa0OQia7jqUwizslfF5XlmnCy7UmJ88GZ0FIsMUiZxmAlYIrIIdUPiAfh5bdA2l9kBsak1X7IJ7q4hXq--6Cb9WF84Iu15kIzZU7T8g=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">https:\/\/ir.avalotx.com<\/a>. The archived webcasts will be available for replay for at least 30 days.<\/p>\n<p><strong>About Avalo Therapeutics<\/strong><\/p>\n<p align=\"justify\">Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo\u2019s lead asset is AVTX-009, an anti-IL-1\u03b2 mAb, targeting inflammatory diseases. Avalo also has two additional drug candidates, which include quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein). For more information about Avalo, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QG8eRhOcy1-S813JWl5PH7toCkX__aa0X1Q3sYtTPtEK0kTQiLZgi9KllyZnZehKNbHn6b32uiizT_5o8-5zoQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.avalotx.com\">www.avalotx.com<\/a>.<\/p>\n<p align=\"justify\"><strong>About AVTX-009\u00a0<\/strong><\/p>\n<p align=\"justify\">AVTX-009 is a humanized monoclonal antibody (IgG4) that binds to interleukin-1\u03b2 (IL-1\u03b2) with high affinity and neutralizes its activity. IL-1\u03b2 is a central driver in the inflammatory process. Overproduction or dysregulation of IL-1\u03b2 is implicated in\u00a0many\u00a0autoimmune and inflammatory diseases. IL-1\u03b2 is a major, validated target for therapeutic intervention. There is evidence that inhibition of IL-1\u03b2 could be effective in hidradenitis suppurativa and a variety of inflammatory\u00a0diseases in dermatology, gastroenterology, and rheumatology.<\/p>\n<p><strong>For media and investor inquiries<\/strong><\/p>\n<p align=\"justify\">Christopher Sullivan, CFO <br \/>Avalo Therapeutics, Inc. <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gqZT7DTgYjn0DlE1PYfG-lFZ-mmJltD_T-I0mXRktyzmpPo0ksot_luR95OqEAXkssY0W-NG5CVyfvFzGHHHAQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"ir@avalotx.com\">ir@avalotx.com<\/a>\u00a0<br \/>410-803-6793<\/p>\n<p align=\"justify\"><em>or<\/em><\/p>\n<p align=\"justify\">Meru Advisors<br \/>Lauren Glaser<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ol3b-dwpAzV1hQPp6leJe2Kb5he9QRHjplcEEvN82uYawzemtmycBSq6PV_bWakYmGewAbC54LwK2ybXDEgNnBL9YJ3U7UAUSueLkXGCfGI=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"lglaser@meruadvisors.com\">lglaser@meruadvisors.com<\/a>\u00a0<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YWNiNzMzMTQtNjQ2Zi00ZTFlLWFjNWUtNzhkMTdkOGM5MmQ2LTEwMzA4OTM=\/tiny\/Avalo-Therapeutics.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WAYNE, Pa. and ROCKVILLE, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) &#8212; Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present at two upcoming investor conferences: Stifel 2024 Healthcare Conference, New [&#8230;]\n","protected":false},"author":1,"featured_media":61553,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-61552","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Avalo Therapeutics to Present at Upcoming Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avalo Therapeutics to Present at Upcoming Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"WAYNE, Pa. and ROCKVILLE, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) &#8212; Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-11T12:05:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/Avalo-Therapeutics.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Avalo Therapeutics to Present at Upcoming Investor Conferences\",\"datePublished\":\"2024-11-11T12:05:20+00:00\",\"dateModified\":\"2024-11-11T12:05:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/\"},\"wordCount\":275,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/\",\"name\":\"Avalo Therapeutics to Present at Upcoming Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-11-11T12:05:20+00:00\",\"dateModified\":\"2024-11-11T12:05:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avalo Therapeutics to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Avalo Therapeutics to Present at Upcoming Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Avalo Therapeutics to Present at Upcoming Investor Conferences","og_description":"WAYNE, Pa. and ROCKVILLE, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) &#8212; Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company","og_url":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-11-11T12:05:20+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/Avalo-Therapeutics.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Avalo Therapeutics to Present at Upcoming Investor Conferences","datePublished":"2024-11-11T12:05:20+00:00","dateModified":"2024-11-11T12:05:20+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/"},"wordCount":275,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/","name":"Avalo Therapeutics to Present at Upcoming Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-11-11T12:05:20+00:00","dateModified":"2024-11-11T12:05:20+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/avalo-therapeutics-to-present-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Avalo Therapeutics to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=61552"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61552\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/61553"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=61552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=61552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=61552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}